![Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials - Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/239698b3-d906-45ef-bf23-f9893153c487/gr1_lrg.jpg)
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials -
![Picture History of the Andrea Doria (Dover Maritime): William H. Miller Jr.: 9780486439280: Amazon.com: Books Picture History of the Andrea Doria (Dover Maritime): William H. Miller Jr.: 9780486439280: Amazon.com: Books](https://images-na.ssl-images-amazon.com/images/I/41OvQYDOhJL.jpg)
Picture History of the Andrea Doria (Dover Maritime): William H. Miller Jr.: 9780486439280: Amazon.com: Books
![Sao Paulo, Brazil. June 4 2021: The Governor of São Paulo João Doria, (PSDB) receives the second dose of the vaccine against Covid-19 (Coronavirus) at the Doctor Victor Araújo Homem de Mello Sao Paulo, Brazil. June 4 2021: The Governor of São Paulo João Doria, (PSDB) receives the second dose of the vaccine against Covid-19 (Coronavirus) at the Doctor Victor Araújo Homem de Mello](https://c8.alamy.com/comp/2G12H01/sao-paulo-brazil-june-4-2021-the-governor-of-so-paulo-joo-doria-psdb-receives-the-second-dose-of-the-vaccine-against-covid-19-coronavirus-at-the-doctor-victor-arajo-homem-de-mello-health-center-in-pinheiros-in-the-capital-this-friday-4-the-immunizing-agent-applied-was-coronavac-and-the-person-responsible-for-making-the-application-was-the-nurse-mnica-calazans-the-first-brazilian-to-be-vaccinated-against-covid-19-photo-roberto-casimirofotoarena-credit-foto-arena-ltdaalamy-live-news-credit-foto-arena-ltdaalamy-live-news-2G12H01.jpg)
Sao Paulo, Brazil. June 4 2021: The Governor of São Paulo João Doria, (PSDB) receives the second dose of the vaccine against Covid-19 (Coronavirus) at the Doctor Victor Araújo Homem de Mello
![SÃO PAULO, SP - 07.05.2021: DORIA RECEIVES FIRST DOSE VACCINE -The governor of the State of São Paulo, João Doria (PSDB) and his wife Bia Doria received this Friday afternoon on May SÃO PAULO, SP - 07.05.2021: DORIA RECEIVES FIRST DOSE VACCINE -The governor of the State of São Paulo, João Doria (PSDB) and his wife Bia Doria received this Friday afternoon on May](https://c8.alamy.com/comp/2FMKNTR/so-paulo-sp-07052021-doria-receives-first-dose-vaccine-the-governor-of-the-state-of-so-paulo-joo-doria-psdb-and-his-wife-bia-doria-received-this-friday-afternoon-on-may-7-2021-the-first-dose-of-the-coronavac-vaccine-against-covid-19-at-the-health-center-i-in-the-pinheiros-region-in-sao-paulo-brazil-nurse-mnica-calazans-the-first-to-receive-the-coronavac-vaccine-against-covid-19-after-approval-by-anvisa-applied-the-vaccine-to-the-governor-photo-aloisio-mauriciofotoarenasipa-usa-2FMKNTR.jpg)
SÃO PAULO, SP - 07.05.2021: DORIA RECEIVES FIRST DOSE VACCINE -The governor of the State of São Paulo, João Doria (PSDB) and his wife Bia Doria received this Friday afternoon on May
![Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abi8961/asset/daf68c0c-1d41-4466-bfe3-65e225d105eb/assets/images/large/scitranslmed.abi8961-f1.jpg)
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine
![Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine](https://www.science.org/cms/asset/05161024-6c28-434d-9b1e-d07a0f9dd24d/keyimage.gif)
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine
![Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells | Science Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells | Science](https://www.science.org/cms/10.1126/science.abj9853/asset/a57cb820-193b-494a-833f-b00108d92c13/assets/images/large/science.abj9853-fa.jpg)
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells | Science
![Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2f5ce501-3e09-4430-986e-6cb55e1db792/gr1_lrg.jpg)
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine
![Twitter 上的 João Doria:"Segunda dose da Vacina do Butantan no braço 💉 https://t.co/FD2GF7z2Cv" / Twitter Twitter 上的 João Doria:"Segunda dose da Vacina do Butantan no braço 💉 https://t.co/FD2GF7z2Cv" / Twitter](https://pbs.twimg.com/media/E3DBUJ1WQAATxf7.jpg:large)
Twitter 上的 João Doria:"Segunda dose da Vacina do Butantan no braço 💉 https://t.co/FD2GF7z2Cv" / Twitter
![Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1087/F3.medium.jpg)
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
Effect of live yeast Saccharomyces cerevisiae supplementation on the performance and cecum microbial profile of suckling piglets | PLOS ONE
![Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/8f385560-6f74-4a64-ae85-b7554efb76ee/gr1.jpg)
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine
![Application of analytical techniques in quality control of printed pharmaceutical dosage forms - Doria Application of analytical techniques in quality control of printed pharmaceutical dosage forms - Doria](http://www.doria.fi//bitstream/handle/10024/148879/vakili_hossein.pdf.jpg?sequence=4&isAllowed=y)
Application of analytical techniques in quality control of printed pharmaceutical dosage forms - Doria
![Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials - Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials -](https://ars.els-cdn.com/content/image/1-s2.0-S1473309921006812-gr3.jpg)